Skip to: Content
Skip to: Site Navigation
Skip to: Search

July 4, 2008 10:31:02 PM CDT

Learn about Newser Points »

Back to the grid

New Blood Thinner Tops Plavix in Trials

Posted Nov 5, 07 9:00 AM CST in Business,  Science & Health    Editor's Choice

(Newser) – An experimental new blood-thinner looks like real competition for top-selling anti-clotting drug Plavix, after proving more effective at preventing heart attacks, strokes, and heart-related death in a recent trial, the AP reports. But “there is a price to pay” for increased effectiveness, wrote one doctor—the new drug caused an extra bleeding death for each heart-related one it prevented.

Despite that risk, many doctors want the FDA to approve prasugrel, because Plavix is expensive and doesn’t work for everyone. Doctors, they argue, won’t prescribe the drug for high-risk patients, like the elderly or previous stroke victims. But the drug’s makers canceled two tests on those groups, “because of a risk of a safety problem,” they said.

Source Associated Press

Editor Recommended

Related News

  • Controversy Rages Over Diabetes Drug's Heart Risks

    Jun 6, 07 12:16 PM CDT
    Controversy Rages Over Diabetes Drug's Heart Risks Troubling questions about the diabetes drug Avandia persisted yesterday as an FDA official revealed that she was barred from recommending a critical warning about the medication, the Times reports. In the run-up to congressional hearings that began today, manufacturer GlaxoSmithKline rushed to disseminate interim clinical findings in hopes of blunting the controversy. More »

  • Stents Show No Lasting Benefit In Heart Study

    Mar 27, 07 8:17 AM CDT
    Stents used to open arteries are no more useful than conventional drug treatment for patients who haven't yet had a heart attack, a new study reveals. In more than 2,000 patients over five years, those who had surgery suffered the same number of heart attacks, strokes, and deaths as those received only drugs. More »

Blood thinner medication Plavix is shown July 28, 2006 in a New York file photo. (AP Photo/Mark Lennihan, File)   (Associated Press)
Dr. Steven Nissen poses in his lab at the Cleveland Clinic beside screens with images of coronary arteries as seen by intravascular ultrasound in Cleveland, Ohio, Jan. 16, 2004. The experimental drug,...   (Associated Press)
prev    next
play

Threads (1 of 1)

Tags

drugs  • medicine  • FDA  • heart disease  • heart attack  • heart  • blood thinner  • Plavix


Loading...

Loading...

Related Thread: Heart Health

Next story from this section »

Today's Most Popular


Other Science & Health Stories

What is Newser?

2008 Codie Finalist

Newser gives you more news in less time. We search for the best and most important stories all over the web, read them for you, and deliver concise and sharp summaries—along with links to the full text. Newser provides a way to stay on top of an ever-expanding horizon of news and opinion—politics, sports, business, trends, technology, personalities, crimes, and controversies. Newser keeps you not just better informed, but, with our signature graphic interface and smart condensed format, more enjoyably informed.

Learn more »